(HealthDay)—A four-month rifapentine-based regimen containing moxifloxacin is noninferior to a standard six-month regimen for treatment of tuberculosis, according to a study published in the May 6 […]
German firm BioNTech said Thursday that patent protection for COVID-19 vaccines is not holding back production or supply of the jabs that it developed with Pfizer.
A state-of-the-art in-utero procedure allows surgeons to correct a birth defect on developing babies inside the womb. But operating on a mother and her unborn child […]